Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13055* | 2021 |
Recruitment of p300/CBP in p53-dependent signal pathways ML Avantaggiati, V Ogryzko, K Gardner, A Giordano, AS Levine, K Kelly Cell 89 (7), 1175-1184, 1997 | 932 | 1997 |
p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation M Fu, C Wang, AT Reutens, J Wang, RH Angeletti, L Siconolfi-Baez, ... Journal of Biological Chemistry 275 (27), 20853-20860, 2000 | 475 | 2000 |
p300 and CBP: partners for life and death A Giordano, ML Avantaggiati Journal of cellular physiology 181 (2), 218-230, 1999 | 379 | 1999 |
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate CD Knights, J Catania, SD Giovanni, S Muratoglu, R Perez, A Swartzbeck, ... The Journal of cell biology 173 (4), 533-544, 2006 | 341 | 2006 |
p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription PL Puri, ML Avantaggiati, C Balsano, N Sang, A Graessmann, A Giordano, ... The EMBO journal, 1997 | 341 | 1997 |
Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth M Fu, M Rao, C Wang, T Sakamaki, J Wang, D Di Vizio, X Zhang, ... Molecular and cellular biology, 2003 | 337 | 2003 |
Hormonal control of androgen receptor function through SIRT1 M Fu, M Liu, AA Sauve, X Jiao, X Zhang, X Wu, MJ Powell, T Yang, W Gu, ... Molecular and cellular biology 26 (21), 8122-8135, 2006 | 295 | 2006 |
The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration S Di Giovanni, CD Knights, M Rao, A Yakovlev, J Beers, J Catania, ... The EMBO journal 25 (17), 4084-4096, 2006 | 257 | 2006 |
Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis C Albanese, M D'Amico, AT Reutens, M Fu, G Watanabe, RJ Lee, ... Journal of Biological Chemistry 274 (48), 34186-34195, 1999 | 231 | 1999 |
The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily A Vassilev, J Yamauchi, T Kotani, C Prives, ML Avantaggiati, J Qin, ... Molecular cell 2 (6), 869-875, 1998 | 214 | 1998 |
The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co‐activator, p300. ML Avantaggiati, M Carbone, A Graessmann, Y Nakatani, B Howard, ... The EMBO journal 15 (9), 2236-2248, 1996 | 201 | 1996 |
Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX G Natoli, ML Avantaggiati, P Chirillo, A Costanzo, M Artini, C Balsano, ... Molecular and cellular biology, 1994 | 195 | 1994 |
A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα-and IFNγ-triggered inflammation V Infantino, V Iacobazzi, A Menga, ML Avantaggiati, F Palmieri Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1839 (11 …, 2014 | 193 | 2014 |
Ras-and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. G Natoli, ML Avantaggiati, P Chirillo, PL Puri, A Ianni, C Balsano, ... Oncogene 9 (10), 2837-2843, 1994 | 187 | 1994 |
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis O Catalina-Rodriguez, VK Kolukula, Y Tomita, A Preet, F Palmieri, ... Oncotarget 3 (10), 1220, 2012 | 185 | 2012 |
Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level C Balsano, ML Avantaggiati, G Natoli, E De Marzio, H Will, M Perricaudet, ... Biochemical and biophysical research communications 176 (3), 985-992, 1991 | 173 | 1991 |
Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo M Levrero, V Barban, S Manteca, A Ballay, C Balsamo, ML Avantaggiati, ... Gene 101 (2), 195-202, 1991 | 162 | 1991 |
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy OC Rodriguez, S Choudhury, V Kolukula, EE Vietsch, J Catania, A Preet, ... Cell cycle 11 (23), 4436-4446, 2012 | 140 | 2012 |
Reactive Oxygen Intermediates Mediate Angiotensin II-induced c-Jun• c-Fos Heterodimer DNA Binding Activity and Proliferative Hypertrophic Responses in Myogenic Cells (∗) PL Puri, ML Avantaggiati, VL Burgio, P Chirillo, D Collepardo, G Natoli, ... Journal of Biological Chemistry 270 (38), 22129-22134, 1995 | 139 | 1995 |